BR1100822A -
Process of prevention or treatment of hyperproliferative vascular disease in a mammal, product, application and pharmaceutical composition.
- Google Patents
Process of prevention or treatment of hyperproliferative vascular disease in a mammal, product, application and pharmaceutical composition.
Info
Publication number
BR1100822A
BR1100822ABR1100822ABR1100822ABR1100822ABR 1100822 ABR1100822 ABR 1100822ABR 1100822 ABR1100822 ABR 1100822ABR 1100822 ABR1100822 ABR 1100822ABR 1100822 ABR1100822 ABR 1100822A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to BR1100822ApriorityCriticalpatent/BR1100822A/en
Publication of BR1100822ApublicationCriticalpatent/BR1100822A/en
BR1100822A1997-05-121997-05-12
Process of prevention or treatment of hyperproliferative vascular disease in a mammal, product, application and pharmaceutical composition.
BR1100822A
(en)
Compound method for the treatment of a glycogen phosphorylase-dependent disease pharmaceutical composition and process for the preparation of a compound
Poly (ADP-ribose) polymerase ("PARP") inhibitors, methods and pharmaceutical compositions for the treatment of neural and cardiovascular tissue injuries
Use of at least one cgrp antagonist for the preparation of a cosmetic, pharmaceutical and / or dermatological composition to treat red skin spots of neurogenic origin, composition obtained and cosmetic treatment procedure using said antagonist.
Compounds 2 'or 3'-deoxy- and 2', 3'-dideoxy-beta-L-pentofuranonucleosides, preparation process and therapeutic application, in particular anti-viral.
Pseudodipeptide product chemical and enzymatic process of preparation of the same application as the product and medicine resulting from the application
A pharmaceutical composition for increasing the bioavailability of piperidinoalkanol anthihamine and its derivatives and for treating allergic reactions in a patient.